about
The progress in optic nerve regeneration, where are we?HB-GAM (pleiotrophin) reverses inhibition of neural regeneration by the CNS extracellular matrix.Endogenous IL-6 of mesenchymal stem cell improves behavioral outcome of hypoxic-ischemic brain damage neonatal rats by supressing apoptosis in astrocyteSustained dual drug delivery of anti-inhibitory molecules for treatment of spinal cord injuryThe rat striatum responds to nigro-striatal degeneration via the increased expression of proteins associated with growth and regeneration of neuronal circuitryA novel eliminase from a marine bacterium that degrades hyaluronan and chondroitin sulfate.Decorin treatment of spinal cord injuryActivation of PI3K and R-Ras signaling promotes the extension of sensory axons on inhibitory chondroitin sulfate proteoglycansGlobal analysis of neuronal phosphoproteome regulation by chondroitin sulfate proteoglycansRAFting the rapids of axon regeneration signaling.Role of CSPG receptor LAR phosphatase in restricting axon regeneration after CNS injuryLocal Delivery of High-Dose Chondroitinase ABC in the Sub-Acute Stage Promotes Axonal Outgrowth and Functional Recovery after Complete Spinal Cord Transection.Prox1 Inhibits Proliferation and Is Required for Differentiation of the Oligodendrocyte Cell Lineage in the Mouse.Col1a1+ perivascular cells in the brain are a source of retinoic acid following strokePoly(ADP-ribose) polymerase 1 is a novel target to promote axonal regeneration.Extracellular matrix assembly: a multiscale deconstructionSignaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease.Glial Contributions to Neural Function and DiseaseMolecular and Cellular Mechanisms of Axonal Regeneration After Spinal Cord Injury.Nebulized solvent ablation of aligned PLLA fibers for the study of neurite response to anisotropic-to-isotropic fiber/film transition (AFFT) boundaries in astrocyte-neuron co-cultures.Migration of Adipose-derived Mesenchymal Stem Cells Stably Expressing Chondroitinase ABC In vitro.The glial scar in spinal cord injury and repair.Glial scar and immune cell involvement in tissue remodeling and repair following acute CNS injuries.Glial cells as progenitors and stem cells: new roles in the healthy and diseased brain.Gene therapy strategies for the treatment of spinal cord injury.Designing drugs that encourage spinal cord injury healing.Influence of the extracellular matrix on endogenous and transplanted stem cells after brain damageMolecular mechanisms of scar-sourced axon growth inhibitorsAxon plasticity in the mammalian central nervous system after injury.Astrocytes: a central element in neurological diseases.Inhibition and enhancement of neural regeneration by chondroitin sulfate proteoglycans.CSPGs inhibit axon branching by impairing mitochondria-dependent regulation of actin dynamics and axonal translation.Cationic Peptides and Peptidomimetics Bind Glycosaminoglycans as Potential Sema3A Pathway Inhibitors.Astrocytes Grown in Alvetex(®) Three Dimensional Scaffolds Retain a Non-reactive Phenotype.Inhibitors of myelination: ECM changes, CSPGs and PTPs.Sugar-dependent modulation of neuronal development, regeneration, and plasticity by chondroitin sulfate proteoglycans.Two PTP receptors mediate CSPG inhibition by convergent and divergent signaling pathways in neurons.Complement Protein C3 Suppresses Axon Growth and Promotes Neuron Loss.Effects of melatonin on severe crush spinal cord injury-induced reactive astrocyte and scar formation.Effects of an immunomodulatory therapy and chondroitinase after spinal cord hemisection injury.
P2860
Q26765313-D8B98CD5-CC0D-416B-9DBD-18AF3BEAFB54Q27345301-919B0DA7-540D-496F-B4BC-ABD66597E750Q28384962-F0FD6C58-48B3-4AC8-BBDA-5AF65F61F6ACQ28603502-C757E2FC-9C19-4DC5-98C7-E1E964C91FC7Q33613315-840551AD-3311-45CD-B259-58DF16808200Q34283564-6D3C619E-3858-4862-AE11-792CF2BF7BD5Q34412717-F972EC87-7226-4EE9-8EED-8FA122E61FB1Q34533332-F8BFC3BB-1B03-45B2-A9C7-A41C3EE4247BQ34634945-E7360DFD-61AC-44C5-8729-4BD020815D07Q35403192-98912AF2-4B52-4284-83D6-5BDFA589A8D6Q35592121-65E8CBB9-62A9-46BF-A498-96161672747EQ35783366-8325AF6C-FCAE-4CE5-BECE-79F2D2E3884DQ35879420-99F34408-EB1D-4736-A1DE-8E4BDEB37D8AQ36079004-8300ABC7-8F01-4386-8927-188DD53E2C55Q36371538-06123F2F-73F9-4425-9715-EC6E11F01485Q36381030-01EF173B-46FD-457A-92A5-93FF7F0CAC1CQ36483870-DF6FBC94-6054-4570-9EA9-E6FB6176B8F0Q36539441-DC661AFF-54DD-4035-BE04-0AF2A30015C4Q36539451-280101C8-FCB9-4F6F-AB19-41036971C0DFQ36934921-6E09DCA4-E4A7-4195-99C8-ABA644D0680EQ37061055-2D0EA305-8061-4748-8D9E-29CF12B886E1Q38122112-6D5C8F0E-5DEB-44E8-8E8E-42C83A40CDF9Q38206485-CC23E4DB-0381-45C1-A03E-AC6E3CCBE2D2Q38225513-3F0B3CA9-0315-4B94-B5C6-FAAB53EB37DAQ38226668-DB325173-6F4A-4413-BF36-4BB642549E59Q38234093-83BBBC0F-3285-4FA9-9CBF-4BBF0BDA032AQ38246263-DC370525-9BBA-40EA-84B6-C8D1B36A6CEDQ38246350-E02A3ED8-520B-4A7D-B651-5EFA1020F9A8Q38248881-38B6D626-9E42-4066-BF7E-9CD09E73121CQ38670385-B54E89DE-2BC3-4908-81ED-4EE5C34AAEA7Q39374452-E19A5220-FAC6-47D3-8A52-AF7AA95D6D92Q39590290-2DFDC5BE-9381-4884-825B-C4A59E425FE1Q39758363-98F290A9-906F-480D-A832-A8CC2C63C383Q39834739-4D014972-21AE-4D56-AFD8-325C921E1DA2Q40804371-A7AD9A4C-A6AB-4AAE-9E05-3064F1B72A72Q42133466-977E4833-F129-4BCF-AB26-DC9223B26DACQ42368114-DFE28C41-EE01-4A70-A056-0473A1A649B4Q42374289-B6AC9B71-0416-42F0-8040-C510C03D4A30Q43797388-A8D64A01-6FC3-4AC6-9E70-DCF1FF04B6A1Q45168459-5584053B-E172-4AB7-88F5-038AFA8F7D4E
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Scar-mediated inhibition and CSPG receptors in the CNS.
@en
type
label
Scar-mediated inhibition and CSPG receptors in the CNS.
@en
prefLabel
Scar-mediated inhibition and CSPG receptors in the CNS.
@en
P2860
P1476
Scar-mediated inhibition and CSPG receptors in the CNS
@en
P2093
Michael E Selzer
P2860
P304
P356
10.1016/J.EXPNEUROL.2012.07.009
P407
P577
2012-07-24T00:00:00Z